Every 10-Q that Ingredion Incorporated (INGR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow INGR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full INGR filings page.
Ingredion reported Q2 2026 net sales of $1.85 billion, up slightly year over year, but operating income declined to $188 million and net income attributable to Ingredion to $114 million ($1.78 diluted EPS) as higher manufacturing costs, a thermal event at its Argo facility, and $45 million of restructuring and impairment charges reduced margins.
For the first half of 2026, net sales were $3.64 billion, operating income $391 million, and net income attributable to Ingredion $256 million ($4.01 diluted EPS), all below 2025, reflecting $56 million of restructuring and impairment (including closure of the Cabo, Brazil facility) and $47 million of acquisition‑related foreign‑exchange hedging losses, partly offset by a $44 million gain on the sale of a majority stake in the Pakistan business.
Ingredion agreed to acquire Tate & Lyle PLC for approximately £2.7 billion (about $3.5 billion), funded with cash, new debt and committed facilities including a $2.75 billion bridge loan and a $1.48 billion delayed‑draw term loan. Tate & Lyle shareholders have approved the court‑sanctioned scheme of arrangement, with completion targeted for the second half of 2027, subject to court and regulatory approvals.
Ingredion ended June 30, 2026 with $948 million of cash and cash equivalents, total debt of $1.78 billion, and stated available liquidity of about $3.9 billion, providing capacity to fund operations, dividends, capital spending and the planned Tate & Lyle transaction.
Ingredion reported weaker results for Q1 2026, with net income attributable to the company falling to $142 million from $197 million a year earlier. Net sales slipped 1% to $1.79 billion, while gross profit declined to $401 million and gross margin narrowed from 26% to 22% due mainly to lower volumes and fixed-cost absorption.
Operating income dropped 26% to $203 million as cost of sales rose and operating expenses increased 4% to $200 million on higher employee costs. Segment performance was mixed: Texture & Healthful Solutions and Latin America grew sales modestly, but U.S./Canada net sales fell 9% and operating income there dropped sharply to $34 million, reflecting production challenges at the Argo facility and softer volumes.
Cash from operating activities decreased to $33 million from $77 million, while capital spending rose to $110 million. The company highlighted strong liquidity of $3.8 billion and total debt of $1.8 billion. Subsequent to quarter end, Ingredion approved a plan to cease operations at its Cabo, Brazil facility and disclosed an Argo “thermal event,” expecting about $43 million of related pre-tax charges and roughly $20 million of direct costs, largely in Q2 2026.
Ingredion (INGR) filed its Q3 2025 10‑Q, reporting softer sales but solid year‑to‑date earnings. Net sales were $1,816 million, down 3% from $1,870 million, as lower raw material costs flowed through price mix and volumes eased in U.S./Canada and LATAM. Gross profit was $455 million and gross margin was 25% versus 26% last year. Operating income was $249 million and diluted EPS was $2.61, compared with $2.83.
For the nine months, net sales were $5,462 million (down 3%) while operating income rose 10% to $796 million on lower corn and input costs; net income attributable to Ingredion reached $564 million versus $552 million. Cash from operations was $539 million; cash and equivalents were $915 million and total debt was $1,798 million. The company approved a new repurchase authorization for up to 8.0 million shares and replaced its revolving credit facility with a $1.0 billion, five‑year agreement. Ingredion also signed a definitive agreement to sell a 51% stake in its Pakistan business, subject to regulatory and other closing conditions; it would retain 20% ownership upon completion.
Ingredion reported mixed results for the quarter and year-to-date periods. Net sales were $1,833 million in Q2 2025 (down 2% year-over-year) and $3,646 million year-to-date (down 3%). Gross profit rose to $477 million in Q2 and $943 million year-to-date as raw material and input costs fell faster than sales, lifting gross margin to 26% year-to-date from 23% a year earlier. Operating income increased to $271 million in Q2 and $547 million year-to-date, a 21% year-over-year rise. Net income attributable to Ingredion was $196 million in Q2 and $393 million year-to-date; diluted EPS were $2.99 and $5.99, respectively.
Liquidity remained substantial with $861 million of cash and $3.7 billion of total available liquidity, while total debt stood at $1.8 billion with most maturities beyond 2026. Cash provided by operating activities declined to $262 million year-to-date from $521 million due to a $250 million working capital increase driven by higher accounts receivable. The company invested $19 million for a 49% stake in the Agrana joint venture, repurchased 409 thousand shares for $55 million year-to-date, and increased its quarterly dividend to $0.80 per share.